(CIX: WRAL30)  1,172.29  up arrow+2.31  (0.2 %)  Updated: 04:44 PM EST, Nov 24 2015
(NQ: Apple)  118.88  up arrow+1.13  (0.96 %)  Updated: 04:30 PM EST, Nov 24 2015
(NY: QUINTILES)  69.16  down arrow-0.08  (-0.12 %)  Updated: 04:15 PM EST, Nov 24 2015
(OP: BASF SE)  81.77  down arrow-0.45  (-0.54 %)  Updated: 03:59 PM EST, Nov 24 2015
(NQ: BioCryst)  10.03  down arrow-0.24  (-2.34 %)  Updated: 04:30 PM EST, Nov 24 2015
(NQ: BioDelivery)  5.95  down arrow-0.15  (-2.46 %)  Updated: 04:30 PM EST, Nov 24 2015
(NQ: CEMP)  32.00  up arrow+0.62  (1.98 %)  Updated: 04:30 PM EST, Nov 24 2015
(NQ: Cisco)  27.27  down arrow-0.16  (-0.58 %)  Updated: 04:30 PM EST, Nov 24 2015
(NQ: Cree)  27.03  up arrow+0.77  (2.93 %)  Updated: 04:30 PM EST, Nov 24 2015
(NQ: DARA)  0.90  down arrow-0.01  (-1.1 %)  Updated: 04:30 PM EST, Nov 24 2015
(NY: EMC)  25.47  up arrow+0.2  (0.79 %)  Updated: 04:15 PM EST, Nov 24 2015
(NQ: Extreme Networks)  4.26  up arrow+0.07  (1.55 %)  Updated: 04:30 PM EST, Nov 24 2015
(NQ: Facebook)  105.74  down arrow-1.21  (-1.13 %)  Updated: 04:30 PM EST, Nov 24 2015
(NY: GLAXOSMITHKLINE)  40.39  down arrow-0.02  (-0.05 %)  Updated: 04:15 PM EST, Nov 24 2015
(NQ: Alphabet)  748.28  down arrow-7.7  (-1.02 %)  Updated: 04:30 PM EST, Nov 24 2015
(NY: IBM)  138.60  up arrow+0.14  (0.1 %)  Updated: 04:15 PM EST, Nov 24 2015
(NY: LH)  121.18  up arrow+0.07  (0.06 %)  Updated: 04:15 PM EST, Nov 24 2015
(OP: Lenovo Group)  22.44  up arrow+0.92  (4.28 %)  Updated: 03:59 PM EST, Nov 24 2015
(NY: MRK)  53.48  down arrow-0.53  (-0.98 %)  Updated: 04:15 PM EST, Nov 24 2015
(NQ: Microsoft)  54.25  up arrow+0.06  (0.11 %)  Updated: 04:30 PM EST, Nov 24 2015
(NQ: NetApp)  30.93  down arrow-0.08  (-0.26 %)  Updated: 04:30 PM EST, Nov 24 2015
(NY: NOVARTIS AG)  86.40  down arrow-0.25  (-0.29 %)  Updated: 04:15 PM EST, Nov 24 2015
(OP: Novozymes A/S)  47.01  down arrow-0.51  (-1.07 %)  Updated: 04:00 PM EST, Nov 24 2015
(NY: Pfizer)  31.97  up arrow+0.64  (2.04 %)  Updated: 04:15 PM EST, Nov 24 2015
(NQ: Pozen)  7.05  down arrow-0.15  (-2.08 %)  Updated: 04:30 PM EST, Nov 24 2015
(NY: Red Hat)  82.05  down arrow-0.7  (-0.85 %)  Updated: 04:15 PM EST, Nov 24 2015
(NQ: BBRY)  7.95  up arrow+0.13  (1.66 %)  Updated: 04:30 PM EST, Nov 24 2015
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  12.67  up arrow+0.46  (3.77 %)  Updated: 04:30 PM EST, Nov 24 2015

Posts tagged “N.C. Biotech Center”

6:30 a.m. today

Attention, startups: Application window now open for One NC matching funds

Dollar sign      The state-run program provides matching grants of up to $50,000 to North Carolina businesses that have received either federal Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) grant awards.

November 9

CED announces keynote speaker for the CED Life Science Conference

Robert J. Lefkowitz, M.D. Entrepreneurial support organization CED announced that Robert J. Lefkowitz, MD will be the keynote speaker for their annual CED Life Science Conference, held this year March 1-2, 2016.

November 4

Chapel Hill's Cardioxyl gets potential $2 billion buyout deal from Bristol-Myers Squibb

Cardioxyl Pharmaceuticals and Bristol-Myers Squibb have signed an agreement under which Bristol-Myers Squibb will acquire Cardioxyl and its assets in potential $2 billion deal.

October 30

NC Biotech Center names Bullock to head economic development

Bill Bullock named VP for economic develoment at NC Biotech Center. The North Carolina Biotechnology Center has named William O. Bullock senior vice president, economic development & statewide operations.

October 27

SynShark making valuable shark oil in tobacco plants

SynShark making shark oil in tobacco plants. Every year an estimated 3 to 5 million sharks are slaughtered for a precious omega-2 oil in their livers called squalene, a clear liquid, lighter than water, that helps them float. SynShark, which has operations in NC, wants to harvest squalene from the leaves of tobacco plants that have been genetically engineered to synthesize the oil.

Updated October 21

Premium Lock NCBIO annual meeting includes legislative review

NCBIO NCBIO, the trade organization for North Carolina biotechnology companies, expects about 200 to 250 at its annual meeting at the NC Biotechnology Center Thursday. Sam Taylor, NCBIO president, said that in addition to two key note speakers, the event includes a review of state and federal policies related to biotech, including what the NC legislature did this year.

Updated October 20

Premium Lock Morrisville-based Humacyte lands a whopping $150M financing

Humacyte Chairman and CEO Carrie Cox. -- Humacyte photo Humacyte, a Duke University regenerative medicine spinout, has raised $150 million committed Series B preferred stock financing. The privately held company's new round of financing, led by a global consortium of new and existing private investors, is among the largest such infusions in the annals of life science company development.

October 16

Premium Lock Pitt CC breaks ground for $16M Science/Tech Center

Artiist's rendering of the Pitt Community College science and technology center Pitt Community College broke ground today for a 75,000-square-foot, $16 million science and technology training facility that will include a biotechnology center.

October 15

Premium Lock NC entrepreneurs pitch unique technologies to investors at BioMarine event

A crab and oyster bait that looks like dessert is one idea entrepreneurs offered investors at the BioMarine Business Convention in Wilmington. A crab and lobster bait that looks like a popular dessert, an oyster bed that disappears when the oysters do - are some of the ideas pitched to investors at the BioMarine Business Conference in Wilimington.

October 15

Premium Lock North Carolina inks deal with Quebec for marine biotech cooperation

The 2015 BioMarine Business Convention in Wilmington closed Wednesday with a landmark agreement of cooperation between North Carolina's Marine Bio-Technologies Center of Innovation (MBCOI) and the government of Quebec, Canada.

(L to R) Louise Fortin, director of the Quebec Trade Office in Atlanta, Dr. Deborah Mosca, CEO of MBCOI, and Associate General Secretary Georges Farrah of the Secretariat aux Affaires Maritimes, Quebec. (L to R) Louise Fortin, director of the Quebec Trade Office in Atlanta, Dr. Deborah Mosca, CEO of MBCOI, and Associate General Secretary Georges Farrah of the Secretariat aux Affaires Maritimes, Quebec.

Updated October 14

Premium Lock North Carolina sustainable seafood featured at BioMarine kickoff

The 2015 BioMarine international conference kicked off in Wilmington Monday evening with a well-attended invite-only networking event aboard the Battleship North Carolina, moored across the Cape Fear River from downtown Wilmington. Refreshments included an array of sustainably produced North Carolina seafood products and local craft beers, as well as the ubiquitous NC barbecue and cornbread. The Marine Bio-Technologies Center of Innovation and the North Carolina Biotechnology Center co-hosted the event.

Caviar from Lenior, NC, among the seafood at the BioMarine reception Caviar from Lenior, NC, among the seafood at the BioMarine reception

October 13

Premium Lock NC Life Science Investment On A Roll

NC life science investments 2015 North Carolina has been seeing a lot of recent rewards for its long-term investment in the life sciences. The recently released CED Innovators Report shows life science companies nailed down more than $268 million in equity investment in the first half of 2015.

Updated October 12

Premium Lock BioMarine Convention brings CEOs, investors to Wilmington

Poster for Wilmington BioMarine Convention The BioMarine Convention of company leaders, investors, and government leaders focused on business deal-making in the diverse marine biotech market space is set to start at the Southeastern North Carolina Biotechnology Center Tuesday and Wednesday.

October 7

Premium Lock Carolina Liquid Chemistries in growth mode after FDA approval

Labworker with Carolina Liquid Chemistries analyzer Carolina Liquid Chemistries (CLC), a Winston-Salem company that makes laboratory diagnostics and testing systems, has received FDA clearance to sell its latest state-of-the-art chemistry analyzer for hospital and clinical use.

October 2

Premium Lock Icagen 'Home Again' at Durham HQ

Icagen HQ returns to Durham Welcome home, Icagen. Well, actually, the Durham drug development company never completely left, but now its once-relocated headquarters is returning to North Carolina from the Boston area with one relocating employee, bringing the head count at its Emperor Boulevard site to 20.

September 29

Premium Lock New faculty member brings UNC Pembroke dollars and recognition

Ben Bahr with students When Ben Bahr, Ph.D., was recruited to the University of North Carolina at Pembroke in 2009 as the inaugural William C. Friday Distinguished Chair and Professor of Molecular Biology and Biochemistry, much was expected. The newly created position was charged with advancing biotechnology research and education at the university and spurring economic development in southeastern North Carolina.

September 29

Premium Lock NovaTarg nabs $3.2M in SBIR grants

Ken Batchelor, president, CEO, NovaTarg NovaTarg, a biotech company developing new treatments for cancer, kidney disease and diabetes, has received $3.2 million in Small Business Innovative Research grants, tripling the firm's current funding.

September 25

Premium Lock Five NC firms to pitch at Biomarine convention

Photo coutesy UNC Wilmington Five North Carolina companies developing marine-oriented technologies are among 15 from around the world that are scheduled to meet with possible investors and partners during an international convention co-hosted by the North Carolina Biotechnology Center.

September 18

Premium Lock Cempra skin antibiotic drug fast-tracked by FDA

Prabhavathi Fernandes, Ph.D., CEO, Cempra NASCAR is North Carolina's best-known contribution to the fast track, but Chapel Hill clinical-stage pharmaceutical company Cempra is even giving NASCAR a run for its money.

September 18

Premium Lock Gov. McCrory to sign state budget today

NC Biotech Center The North Carolina legislature has passed a $21.74 billion budget Gov. Pat McCrory says he will sign it today (Friday). The 429-page billl reduces personal income tax rates, fails to renew the 35 percent renewable energy tax break, and continues funding the NC Biotechnology Center at $13.6 million, despite being targeted for a cut earlier, and creates a "venture capital multiplier fund."

Techwire Inside Partners
The Skinny: A Blog by Rick Smith